Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

News

Vall d’Hebron study detects high prevalence of schistosomiasis in an Angolan region

The research, carried out by members from the PROSICS and VHIR, has revealed that 61% of school-age children in Cubal carry the eggs of the worm that causes this disease.

News

The 9th Anual Conference brings the future of personalized medicine

More than 300 people attended the 19th Vall d'Hebron University Hospital Annual Conference, featured by Professor Edward Abrahams, president of the Personalized Medicine Coalition. Before the conference, the Vall d'Hebron Institute of Research (VHIR) celebrated the Scientific Session, with major cha

News

Buy the charity calendar of the Vall d’Hebron Market!

For the second consecutive year, the sellers from the local market will raise funds for research projects with the aim to improve people's health.

News

A must in your agenda: Dr. Edward Abrahams’ conference and the new Scientific Session

A must in your agenda: Dr. Edward Abrahams’ conference and the new Scientific Session

News

The bank of primary immunodeficiencies gets 100 samples

Researchers started the collection at the beginning of 2015, with the aim to become the biobank of reference in Catalonia.

News

Discover the winners of the 5th VHIR’ Scientific Images Contest

Discover the winners of the 5th VHIR’ Scientific Images Contest

News

Móra d’Ebre raises over 8,500 euros for child cancer research

Móra d’Ebre raises over 8,500 euros for child cancer research

News

The Barcelona’s Medical Board acknowledges the career of VHIR and WIDER researchers

The professional association has also given the Professional Excellence Award to clinicians from Vall d'Hebron.

News

VHIR researchers bring science to l'Illa Diagonal

Coinciding with the Black Friday, members of the Research Unit in Gynecology will make campaign of the Giving Tuesday.

News

The NOTES-WIDER Barcelona course arrives to the 9th edition

More than 100 professionals are doing this course that has become the world's most outstanding forum about advanced endoscopic and transluminal surgery.

News

Mutual Medica awards two VHIR researchers

Dr. Marta Torres, from the Headache and Neurological Pain group, and Dr. Israel Molina, from the Infectious Diseases group, have been awarded.

News

Camping Laguna donates nearly 3,200 euros for child cancer research at VHIR

The clients and the direction of the camping, located in Castelló d'Empúries, held a charity raffle for Joan Silva, a young patient treated at Vall d'Hebron.

News

Diario Médico awards VHIR for the methodology that will help doctors choosing the most efficient treatment for hepatitis C

During the celebration of the 14th edition of Best Ideas VHIO also received a prize for the liquid biopsy.

News

VHIR is awarded by the Catalan Association of Neuromuscular Diseases

The association has given the FEM Pinya award to the Institute, for its commitment with research in neuromuscular diseases.

News

SOM Biotech and Vall d'Hebron successfully complete a clinical trial in patients with TTR amyloidosis

The clinical trial of SOM0226 compound, a repositioned drug developed by the biopharma, started one year ago coordinated by Dr. Gámez.

News

Discovered an anti-diabetic treatment with added benefits for diabetic retinopathy

They have demonstrated that the GLP-1 hormone and its analogous can avoid retinal neurodegeneration by topical and subcutaneous administration.

News

Vall d’Hebron coordinarà un col·loqui sobre la resistència als antibiòtics

Within the World Antibiotic Awareness Week, Dr. Gavaldà and Dr. Almirante from Infectious Diseases group at VHIR coordinate a meeting at Col.legi Oficial de Metges.

News

David, Friend of Vall d’Hebron, will help to improve people’s health

Thanks to his donation, together with the donations of all the Friends of VHIR, researchers will advance in today's research and tomorrow's medicine.

News

New methodology to improve the drug response of breast and colon cancer with nanomedicine

VHIR researchers have developed a system to identify cancer stem cells, which are the most resistant and the responsible of the relapses in cancer.